Business PR Newswire Green Industry, Bright Future – Deye 2025 Dubai Distributor Summit Successfully Held rvrisingnetwork December 8, 2025 DUBAI, UAE, Dec. 5, 2025 /PRNewswire/ — In November 2025, Deye successfully hosted the “Green…
News PR Newswire SINEXCEL Receives Frost & Sullivan’s 2025 China Ultra-Fast and Megawatt Charging Competitive Strategy Leadership Recognition rvrisingnetwork November 18, 2025 SHENZHEN, China, Nov. 18, 2025 /PRNewswire/ — Frost & Sullivan has recognized SINEXCEL with the prestigious…
News PR Newswire JA Solar and 5B Sign Strategic Module Supply Agreement for 100MW+ Project in Western Australia rvrisingnetwork October 31, 2025 BEIJING, Oct. 30, 2025 /PRNewswire/ — JA Solar, a trusted global partner in green energy,…
PR Newswire World China Pavilion at Osaka Expo 2025 wins the Gold Award! Unilumin provides a comprehensive multimedia solution rvrisingnetwork October 30, 2025 OSAKA, Japan, Oct. 29, 2025 /PRNewswire/ — On the evening of October 12, 2025, the…
Business PR Newswire AgiBot Robotics Debuted at IROS 2025, the AgiBot World Challenge Concluded Successfully rvrisingnetwork October 30, 2025 SHANGHAI, Oct. 30, 2025 /PRNewswire/ — From October 19 to 25, 2025, the 2025 IEEE/RSJ…
Health PR Newswire FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease rvrisingnetwork October 23, 2025 TAIPEI, Oct. 22, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced…
Health PR Newswire FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease rvrisingnetwork October 23, 2025 TAIPEI, Oct. 23, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced…
Business PR Newswire Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM rvrisingnetwork October 21, 2025 In the OptiTROP-Lung04 trial, a total of 376 patients were randomized (1:1) to receive sac-TMT…
Business PR Newswire Kelun-Biotech’s Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC rvrisingnetwork October 18, 2025 CHENGDU, China, Oct. 17, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company’s human epidermal…
PR Newswire World Linglong Tire’s 50th Anniversary Celebration Successfully Held in Madrid rvrisingnetwork October 15, 2025 MADRID, Oct. 15, 2025 /PRNewswire/ — Recently, the Linglong Tire 50th Anniversary Celebration was successfully…